1 Min Read
Sept 12 (Reuters) - Merck Canada Inc:
* BRENZYS approved in Canada for treatment of adult patients with moderate to severe rheumatoid arthritis and ankylosing spondylitis Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.